Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
A Bitter Pill for Novo, Green Backlash Hits Orsted, Schneider Electric Down | Stock Movers
Posted
April 22, 2025
Views
204
Likes
2
Engagement
0.98%
April 22, 2025
204
2
0.98%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
4:21Now PlayingOn this episode of Stock Movers:
- Novo Nordisk slumped after a pill from rival Eli Lilly helped patients shed weight and control blood sugar about as well as its injected blockbuster Ozempic. The stock dropped as much as 9.8% to 380 kroner early in Copenhagen, the first trading day since the Thursday announcement that buoyed Lilly.
- The Trump administration halted work on an offshore wind farm being built off New York amid a broader review of the sector’s projects. The halt is the latest — and perhaps biggest — blow to a sector that seemed on the verge of major growth just four years ago.
- European electrification stocks are trading lower and underperforming the broader market on Tuesday after an analyst at Wells Fargo Securities said Amazon.com’s web services business is pausing some data center leases. Kevin Miller, vice president of global data centers at Amazon Web Services, said in a post on LinkedIn there “haven’t been any recent fundamental changes in our expansion plans,” though there has been “routine capacity management,” which can be based on such factors as price and location
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
A Bitter Pill for Novo, Green Backlash Hits Orsted, Schneider Electric Down
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
